Showing results (1-10 of 229) with videos related to
Sort By:
Pageof 23
Cell and Tissue Research|January 26, 2021
Immune regulation in renal inflammationKatrin Neumann, Gisa TiegsInternational Journal of Molecular Sciences|April 20, 2019
Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future PerspectivesAaron Ochel, Gisa Tiegs, Katrin NeumannCells|May 28, 2022
Pathogenic T-Cell Responses in Immune-Mediated GlomerulonephritisAlexandra Linke, Gisa Tiegs, Katrin NeumannInternational Journal of Molecular Sciences|September 15, 2018
NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver InflammationKatrin Neumann, Birgit Schiller, Gisa TiegsCellular & Molecular Immunology|April 5, 2016
Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cellsAndrea Kristina Horst, Katrin Neumann, Linda Diehl, et al.Cellular & Molecular Immunology|October 28, 2020
Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver diseaseAndrea Kristina Horst, Kingsley Gideon Kumashie, Katrin Neumann, et al.Scientific Reports|January 25, 2020
Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4+ T cellsSilja Steinmann, Marek Schoedsack, Fabian Heinrich, et al.Frontiers in Immunology|April 4, 2024
The ST2+ Treg/amphiregulin axis protects from immune-mediated hepatitisSelina Wachtendorf, Fitriasari Jonin, Aaron Ochel, et al.Scientific Reports|March 14, 2019
Deletion of tumour necrosis factor α receptor 1 elicits an increased TH17 immune response in the chronically inflamed liverLaura Berkhout, Roja Barikbin, Birgit Schiller, et al.Journal of Leukocyte Biology|April 15, 2008
Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factorsMarkus Biburger, Gisa TiegsPageof 23